MACKENZIE FINANCIAL CORP
Position in CRL — Charles River Laboratories International, Inc.
CIK 919859
TORONTO ONTARIO, A6
Position in CRL
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$350,617
-$102,252,383 QoQ
Shares Held
1,546
-99.7% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#345
of 570 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CRL Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026MACKENZIE FINANCIAL CORP holds $567,039,905 across 20 Diagnostics & Research names. CRL ranks #18 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | DHR |
Danaher Corp /De/
|
1,044,132 | $198,886,263 | |
| 2 | TMO |
Thermo Fisher Scientific Inc.
|
331,992 | $166,447,509 | |
| 3 | DGX |
Quest Diagnostics Inc
|
333,295 | $70,641,875 | |
| 4 | IDXX |
Idexx Laboratories Inc /De
|
44,162 | $23,248,643 | |
| 5 | CSTL |
Castle Biosciences Inc
|
793,507 | $18,925,141 | |
| 6 | NTRA |
Natera, Inc.
|
53,116 | $14,418,338 | |
| 7 | A |
Agilent Technologies, Inc.
|
90,705 | $12,048,345 | |
| 8 | LH |
Labcorp Holdings Inc.
|
35,179 | $9,850,120 |
All Filings in CRL
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $350,617 | 1,546 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $102,603,000 | 594,800 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $155,888,832 | 781,476 | Shares | Sole | 2026-02-18 | |
| 2025-09-30 | $155,738,250 | 995,387 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $152,040,894 | 1,002,049 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $150,964,184 | 1,002,951 | Shares | Sole | 2025-05-07 | |
| 2024-12-31 | $180,367,675 | 977,073 | Shares | Sole | 2025-05-02 | |
| 2024-09-30 | $191,310,657 | 971,268 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $191,945,872 | 929,160 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $252,470,397 | 931,797 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $216,981,631 | 917,858 | Shares | Sole | 2024-01-30 | |
| 2023-09-30 | $181,016,731 | 923,649 | Shares | Sole | 2023-10-25 | |
| 2023-06-30 | $193,249,605 | 919,142 | Shares | Sole | 2023-08-03 | |
| 2023-03-31 | $174,798,320 | 866,110 | Shares | Sole | 2023-04-24 | |
| 2022-12-31 | $174,445,510 | 800,576 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $139,890,360 | 710,825 | Shares | Sole | 2022-10-07 | |
| 2022-06-30 | $211,238,458 | 987,234 | Shares | Sole | 2022-08-10 | |
| 2022-03-31 | $243,139,089 | 856,214 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $114,199,380 | 303,093 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $126,653,787 | 306,913 | Shares | Sole | 2021-11-08 | |
| 2021-06-30 | $165,522,923 | 447,456 | Shares | Sole | 2021-08-11 | |
| 2021-03-31 | $75,874,305 | 261,789 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $107,275,641 | 429,343 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $83,462,450 | 368,569 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $63,760,841 | 365,706 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $32,973,750 | 261,261 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||